Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Sep 3;18(9):1486-1504.
doi: 10.1093/ecco-jcc/jjae057.

Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

Michael Youssef  1 , Nariman Hossein-Javaheri  2 , Tedi Hoxha  1 , Christina Mallouk  3 , Parul Tandon  4
Affiliations
Meta-Analysis

Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

Michael Youssef et al. J Crohns Colitis. .

Abstract

Background and aims: The impact of inflammatory bowel disease [IBD] on work productivity remains unclear. In this systematic review and meta-analysis, we quantify work-related outcomes and employment data among persons with IBD.

Methods: A systematic literature search was conducted in MEDLINE, EMBASE, the Cochrane library, Scopus, ProQuest, and clinicaltrials.gov from inception to February 2023, to identify studies on work productivity in persons with IBD aged > 18 years. Work productivity was defined primarily by the Work Productivity and Activity Impairment [WPAI] questionnaire which includes absenteeism, presenteeism, overall work impairment, and non-work activity impairment. In addition, we included data on employment, sick leaves, disability pensions, and indirect costs due to productivity loss. Pooled effect analysis was conducted using a random-effects model for pooled estimates of continuous and proportional data with 95% confidence intervals.

Results: Among all patients with IBD, the pooled estimates were 16.4% for absenteeism, 35.9% for presenteeism, 39.4% for overall work impairment, and 46.0% for non-work activity impairment. Indirect costs from overall work impairment were 5131.09 euros/patient/year. Only two-thirds of IBD patients were employed, and one in three lost their jobs due to IBD. Among those employed, 39.5% report sick days, 21.3% report work disability, and 12.3% receive disability pensions. Most studies demonstrate clinically meaningful improvements in work productivity with medical and/or surgical therapies.

Conclusion: Persons with IBD experience significant work impairment and associated indirect costs. This highlights the need for appropriate workplace accommodations and timely medical therapy to alleviate the burden of disease and improve work outcomes.

Keywords: Inflammatory bowel disease; WPAI; work productivity.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any relevant conflicts of interest to declare.

Figures

Graphical Abstract
Graphical Abstract
Figure 1
Figure 1
PRISMA flowchart.
Figure 2
Figure 2
Comparison of A] absenteeism, B] presenteeism, C] total work impairment, D] non-work activity impairment, by mean differences based on disease activity.
Figure 3
Figure 3
Comparison of A] employment and B] disability pensions by ORs based on disease activity.
See this image and copyright information in PMC

References

    1. Alatab S, Sepanlou SG, Ikuta K, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:17–30. - PMC - PubMed
    1. Leso V, Gervetti P, Macrini MC, Russo F, Iavicoli I.. Inflammatory bowel diseases and work disability: a systematic review of predictive factors. Eur Rev Med Pharmacol Sci 2021;25:165–81. - PubMed
    1. Mak WY, Zhao M, Ng SC, Burisch J.. The epidemiology of inflammatory bowel disease: east meets west. J Gastroenterol Hepatol 2020;35:380–9. - PubMed
    1. van Gennep S, de Boer NKH, Gielen ME, et al. Impaired quality of working life in inflammatory bowel disease patients. Dig Dis Sci 2021;66:2916–24. - PMC - PubMed
    1. Reilly MC, Zbrozek AS, Dukes EM.. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEcon 1993;4:353–65. - PubMed

MeSH terms